Kite inks research pact with Appia Bio to develop allogeneic cell therapies
07 Aug 2021 //
PHARMABIZ
Gilead`s Kite inks up to $875M blood cancer pact with Appia Bio
07 Aug 2021 //
FIERCEBIOTECH
Kite and Appia Bio to develop allogeneic cell therapies for blood cancer
06 Aug 2021 //
PHARMACEUTICAL TECHNOLOGY